MSB 3.21% $1.13 mesoblast limited

MSB 2023 - awaiting for Ryoncil approval, page-373

  1. 587 Posts.
    lightbulb Created with Sketch. 280
    @gavin66 COVID ARDS will definitely go ahead with planned trial a collaboration with vanderbilt and (my guess NIH funding ) based on another little qanda i had with the great man himself at agm

    *remember this number will tell you why later 12,000,000

    oh and fyi to all longs ...the great man also said a recent potential partner on this indication could still be in play once we get our first approval over the line with FDA

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.